Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Kadmon Corporation, LLC Identifier:
First received: July 2, 2004
Last updated: October 17, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)